LabCorp Expands Drug Development Solutions with Acquisition of Sciformix

Sciformix extends Covance’s pharmacovigilance capabilities for post-approval safety solutions BURLINGTON, N.C. --(BUSINESS WIRE)--Jun. 11, 2018-- LabCorp® (NYSE: LH), a leading global life sciences company, announced today that it has acquired Sciformix Corporation , a scientific process

LabCorp is Scheduled to Present at the 38th Annual William Blair Growth Stock Conference

BURLINGTON, N.C. --(BUSINESS WIRE)--Jun. 5, 2018-- LabCorp® (NYSE: LH) today announced it will participate at the 38 th Annual William Blair Growth Stock Conference . LabCorp’s presentation is planned for Tuesday, June 12, 2018 at 12:10 PM (CT) . A live audio webcast of the presentation will be

LabCorp and Unilabs Collaborate to Expand Global Reach of Precision Medicine Capabilities to Serve Patients, Physicians and Pharma

Collaboration creates global laboratory network for the development and commercialization of companion diagnostics BURLINGTON, N.C. & GENEVA--(BUSINESS WIRE)--Jun. 1, 2018-- LabCorp® (NYSE: LH), a leading global life sciences company, and Unilabs, a leading European provider of clinical laboratory

LabCorp to Become a Preferred National Laboratory for Aetna

Agreement Expands Access to High-Quality, High-Value Laboratory Services for All Aetna Members HARTFORD, Conn. & BURLINGTON, N.C. --(BUSINESS WIRE)--May 25, 2018-- Aetna (NYSE: AET ) and LabCorp® (NYSE: LH) today extended and expanded their existing agreement, making LabCorp a preferred national

UnitedHealthcare Establishes Long-term Strategic Partnership with LabCorp

  LabCorp will continue participating as a national provider of laboratory services to all UnitedHealthcare plan participants   Partnership will include broad range of value-based programs, rewarding high-quality, easily accessible laboratory services at the best value and real-time data sharing to

LabCorp to Webcast Its Annual Meeting of Shareholders

BURLINGTON, N.C. --(BUSINESS WIRE)--May 3, 2018-- LabCorp® (NYSE: LH) today announced that its Annual Meeting of Shareholders will be webcast live beginning May 10, 2018 at 9:00 a.m. Eastern Daylight Time via the Company website at www.labcorp.com . An archived replay of the audio webcast will be

LabCorp Announces Collaboration with The Recovery Platform to Assist Physicians Treating Patients with Opioid Dependency

Combination of LabCorp’s testing and The Recovery Platform’s software supports compliance with medication-assisted treatment BURLINGTON, N.C. --(BUSINESS WIRE)--May 1, 2018-- LabCorp® (NYSE: LH), a leading global life sciences company, and The Recovery Platform are announcing a new collaboration to

LabCorp Enters into Definitive Agreement to Sell Covance Food Solutions to Eurofins for $670 Million

Transaction reflects LabCorp’s mission to improve health and improve lives, and Eurofins’ commitment to be a scientific leader in laboratory services for the food supply industry BURLINGTON, N.C. --(BUSINESS WIRE)--Apr. 30, 2018-- LabCorp® (NYSE: LH), a leading global life sciences company,

LabCorp Announces Strong 2018 First Quarter Results and Updates 2018 Guidance

Effective January 1, 2018 , the Company adopted the new revenue recognition accounting standard (ASC 606) and restated financial results for 2016 and 2017. Unless otherwise indicated, all financial results in 2017 and comparisons to financial results in 2017 have been restated in these bullets and

LabCorp and Mount Sinai Health System Enhance Laboratory Operations to Improve Patient Care

BURLINGTON, N.C. --(BUSINESS WIRE)--Apr. 24, 2018-- LabCorp® (NYSE: LH) and the Mount Sinai Health System today announced a significant milestone in achieving their common goal of improving laboratory services and patient care. LabCorp, a leading global life sciences company, and Mount Sinai, one